Founded in 2018, Surface Ophthalmics (Surface) stands as a pioneering biopharmaceutical firm devoted to the discovery and market introduction of advanced treatments for diseases affecting the ocular surface. Our mission is to address critical care needs within eye care by harnessing in-depth knowledge, a dynamic strategy, a focus on efficiency, and distinctive clinical benefits. Surface boasts a remarkable team of leaders and advisors, each distinguished by their outstanding leadership qualities, exceptional skills, and comprehensive industry knowledge—factors that are vital to the company’s achievements.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Critical Care Needs Within Eye Care By Harnessing In-Depth Knowledge
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://surfaceophthalmics.com/
- Keywords
- Representative jobs.
Surface Ophthalmics Questions
Surface Ophthalmics's website is https://surfaceophthalmics.com/
Surface Ophthalmics's LinkedIn profile is https://www.linkedin.com/company/surface-ophthalmics
Surface Ophthalmics has
2 employees.
View email and phone details for 2
employees at Surface Ophthalmics.
Surface Ophthalmics's industry is
Pharmaceutical Manufacturing
Surface Ophthalmics's top competitors are
Apellis Pharmaceuticals,
Lumibird Medical Usa,
Imprimisrx® - A Harrow Company,
Eyepoint,
Neurotech Pharmaceuticals, Inc.,
Sydnexis,
Melt Pharmaceuticals,
Lenz Therapeutics,
Scoutpro Osmolarity System,
Harrow.
Surface Ophthalmics's categories are Pharmaceutical Manufacturing
Surface Ophthalmics's founding year is 2018
